MTOR and cancer: Recently, small molecule inhibitors have been designed to interrupt the DEPTOR PDZ/mTOR interaction and have shown selective cytotoxicity against this type of cancer (Lee et al., 2017; Shi et al., 2016; Vega et al., 2019).